The price of Alkermes plc (NASDAQ: ALKS) closed at $27.71 in the last session, up 0.04% from day before closing price of $27.70. In other words, the price has increased by $+0.01 from its previous closing price. On the day, 1929840 shares were traded.
Ratios:
We take a closer look at ALKS’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.99 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.10. For the most recent quarter (mrq), Quick Ratio is recorded 2.50 and its Current Ratio is at 2.86. In the meantime, Its Debt-to-Equity ratio is 0.31 whereas as Long-Term Debt/Eq ratio is at 0.30.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on March 19, 2024, initiated with a Outperform rating and assigned the stock a target price of $37.
On February 20, 2024, UBS Downgraded its rating to Sell which previously was Neutral but kept the price unchanged to $25.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 18 ’24 when Nichols Christian Todd sold 10,417 shares for $28.10 per share. The transaction valued at 292,740 led to the insider holds 65,911 shares of the business.
Parisi Samuel Joseph sold 2,559 shares of ALKS for $75,874 on Feb 27 ’24. The VP, Finance (Interim PAO) now owns 7,717 shares after completing the transaction at $29.65 per share. On Feb 15 ’24, another insider, LAURENCIN CATO T, who serves as the Director of the company, sold 2,690 shares for $31.85 each. As a result, the insider received 85,676 and left with 15,169 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALKS now has a Market Capitalization of 4.63B and an Enterprise Value of 4.23B. As of this moment, Alkermes’s Price-to-Earnings (P/E) ratio for their current fiscal year is 13.39, and their Forward P/E ratio for the next fiscal year is 10.95. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.54. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.78 while its Price-to-Book (P/B) ratio in mrq is 3.85. Its current Enterprise Value per Revenue stands at 2.54 whereas that against EBITDA is 8.14.
Stock Price History:
Over the past 52 weeks, ALKS has reached a high of $32.88, while it has fallen to a 52-week low of $20.46. The 50-Day Moving Average of the stock is 28.51, while the 200-Day Moving Average is calculated to be 28.29.
Shares Statistics:
According to the various share statistics, ALKS traded on average about 1.88M shares per day over the past 3-months and 2.67M shares per day over the past 10 days. A total of 166.98M shares are outstanding, with a floating share count of 164.61M. Insiders hold about 1.47% of the company’s shares, while institutions hold 106.26% stake in the company. Shares short for ALKS as of Feb 29, 2024 were 13.02M with a Short Ratio of 6.94, compared to 11.66M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 7.79% and a Short% of Float of 8.89%.
Earnings Estimates
The company has 6 analysts who recommend its stock at the moment. On average, analysts expect EPS of $0.69 for the current quarter, with a high estimate of $0.92 and a low estimate of $0.58, while EPS last year was $0.01. The consensus estimate for the next quarter is $0.79, with high estimates of $0.95 and low estimates of $0.71.
Analysts are recommending an EPS of between $2.85 and $2.7 for the fiscal current year, implying an average EPS of $2.79. EPS for the following year is $2.7, with 7 analysts recommending between $3.26 and $2.35.
Revenue Estimates
According to 8 analysts, the current quarter’s revenue is expected to be $377.5M. It ranges from a high estimate of $415.01M to a low estimate of $366M. As of the current estimate, Alkermes plc’s year-ago sales were $287.6M, an estimated increase of 31.30% from the year-ago figure. For the next quarter, 7 analysts are estimating revenue of $393.94M, a decrease of -36.20% less than the figure of $31.30% in the same quarter last year. There is a high estimate of $426.01M for the next quarter, whereas the lowest estimate is $384.96M.
A total of 11 analysts have provided revenue estimates for ALKS’s current fiscal year. The highest revenue estimate was $1.56B, while the lowest revenue estimate was $1.48B, resulting in an average revenue estimate of $1.53B. In the same quarter a year ago, actual revenue was $1.66B, down -8.10% from the average estimate. Based on 10 analysts’ estimates, the company’s revenue will be $1.54B in the next fiscal year. The high estimate is $1.74B and the low estimate is $1.43B. The average revenue growth estimate for next year is up 0.80% from the average revenue estimate for this year.
